Evaluation de l’entretien de l’anesthésie générale sous Xénon comparé au Desflurane au cours de l’endartérectomie carotidienne, étude prospective, randomisée et comparative

INTERVENTION: Trade Name: LENOXE 100% Pharmaceutical Form: Inhalation vapour* Trade Name: SUPRANE Pharmaceutical Form: Inhalation vapour* CONDITION: Carotid artery stenosis ; MedDRA version: 12.1 Level: LLT Classification code 10007687 Term: Carotid artery stenosis PRIMARY OUTCOME: Main Objective: Compare the hemodynamic stability in ASA class 2‐3 patients scheduled for an carotid endarterectomy surgery during general anesthesia maintained by Xenon or Desflurane.; Primary end point(s): The number of hypotensive events, defined as a mean arterial pressure less than 70 mmHg, observed in the two groups. ; Secondary Objective: ‐ Compare the recovery characteristics in patients scheduled for an carotid endarterectomy surgery after general anesthesia maintained by Xenon or Desflurane.; ‐ Compare the quality of clinical recovery in patients scheduled for an carotid endarterectomy surgery after general anesthesia maintained by Xenon or Desflurane.; ‐ Compare the incidence of postoperative myocardial ischemia after carotid endarterectomy surgery under general anesthesia maintained by Xenon or Desflurane. ; INCLUSION CRITERIA: ‐ Patients of more than 18 years old. ‐ ASA 2 ‐3 patients scheduled for carotid endarterectomy under general anesthesia. ‐ Have given his/her writing informed consent to participate in the study. ‐ Patients able to understand the protocol of the study. ‐ Patients having a national health insurance . Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18‐64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range